Alkermes Plc · NASDAQ:ALKS

Hopkinson Craig C. sold 9,000 Alkermes Plc shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 1, 2026

On Jul 1, 2026, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) sold 9,000 Alkermes Plc shares at an average US$51.51 for US$464K under a trading plan, leaving 73,389 shares. Filed Jul 1, 2026 (Form 4).

Sold
9,000 shares
Price
US$51.51 average (US$51.46 to US$52.13)
Value
US$464K
Holding after
73,389 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP R&D, Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Ordinary SharesOption exercise5,000US$19.3482,389Direct
Jul 1, 2026Ordinary SharesSale8,300US$51.4674,089Direct
Jul 1, 2026Ordinary SharesSale700US$52.1373,389Direct

Source

View original at SEC

Related